NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM.
Sloan AE, Winter K, Gilbert MR, Aldape K, Choi S, Wen PY, Butowski N, Iwamoto FM, Raval RR, Voloschin AD, Kamiya-Matsuoka C, Won M, Mehta MP.
Sloan AE, et al. Among authors: choi s.
Neuro Oncol. 2024 Jun 14:noae058. doi: 10.1093/neuonc/noae058. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38874333